These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 24026059)
1. [Photodynamic therapy of bladder cancer. A new option]. Neuhaus J; Schastak S; Berndt M; Walther J; Dietel A; Sieger N; Stolzenburg JU Urologe A; 2013 Sep; 52(9):1225-32. PubMed ID: 24026059 [TBL] [Abstract][Full Text] [Related]
2. Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model. Berndt-Paetz M; Schulze P; Stenglein PC; Weimann A; Wang Q; Horn LC; Riyad YM; Griebel J; Hermann R; Glasow A; Stolzenburg JU; Neuhaus J Mol Cancer Ther; 2019 Apr; 18(4):743-750. PubMed ID: 30824608 [TBL] [Abstract][Full Text] [Related]
3. Tetrahydroporphyrin-tetratosylat (THPTS): A near-infrared photosensitizer for targeted and efficient photodynamic therapy (PDT) of human bladder carcinoma. An in vitro study. Berndt-Paetz M; Weimann A; Sieger N; Schastak S; Riyad YM; Griebel J; Arthanareeswaran VKA; Stolzenburg JU; Neuhaus J Photodiagnosis Photodyn Ther; 2017 Jun; 18():244-251. PubMed ID: 28279796 [TBL] [Abstract][Full Text] [Related]
4. Initiation of apoptosis by photodynamic therapy using a novel positively charged and water-soluble near infra-red photosensitizer and white light irradiation. Schastak S; Yafai Y; Geyer W; Kostenich G; Orenstein A; Wiedemann P Methods Find Exp Clin Pharmacol; 2008; 30(1):17-23. PubMed ID: 18389094 [TBL] [Abstract][Full Text] [Related]
5. Characterization of radical types, penetration profile and distribution pattern of the topically applied photosensitizer THPTS in porcine skin ex vivo. Lohan SB; Kröger M; Schleusener J; Darvin ME; Lademann J; Streit I; Meinke MC Eur J Pharm Biopharm; 2021 May; 162():50-58. PubMed ID: 33691169 [TBL] [Abstract][Full Text] [Related]
6. Chemical modification of a tetrapyrrole-type photosensitizer: tuning application and photochemical action beyond the singlet oxygen channel. Riyad YM; Naumov S; Schastak S; Griebel J; Kahnt A; Häupl T; Neuhaus J; Abel B; Hermann R J Phys Chem B; 2014 Oct; 118(40):11646-58. PubMed ID: 25207950 [TBL] [Abstract][Full Text] [Related]
7. Studies of the photosensitizer disulfonated meso-tetraphenyl chlorin in an orthotopic rat bladder tumor model. Baglo Y; Peng Q; Hagen L; Berg K; Høgset A; Drabløs F; Gederaas OA Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):58-66. PubMed ID: 25575731 [TBL] [Abstract][Full Text] [Related]
8. [Photodynamic therapy of urinary bladder cancer using a chlorin based photosensitizer]. Iagudaev DM; Martov AG; Sorokatyĭ AE; Geĭnits AV Urologiia; 2006; (3):24-7. PubMed ID: 16889085 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model. Asanuma H; Arai T; Morimoto Y; Kawauchi S; Satoh H; Seguchi K; Kikuchi M; Murai M J Urol; 2005 Nov; 174(5):2016-21. PubMed ID: 16217385 [TBL] [Abstract][Full Text] [Related]
11. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma. Grönlund-Pakkanen S; Wahlfors J; Talja M; Kosma VM; Pakkanen TM; Ala-Opas M; Alhava E; Moore RB BJU Int; 2003 Jul; 92(1):125-30. PubMed ID: 12823396 [TBL] [Abstract][Full Text] [Related]
12. Improved pharmacokinetics, biodistribution and necrosis in vivo using a new near infra-red photosensitizer: tetrahydroporphyrin tetratosylat. Schastak S; Jean B; Handzel R; Kostenich G; Hermann R; Sack U; Orenstein A; Wang YS; Wiedemann P J Photochem Photobiol B; 2005 Mar; 78(3):203-13. PubMed ID: 15708517 [TBL] [Abstract][Full Text] [Related]
14. Advances in Management of Bladder Cancer-The Role of Photodynamic Therapy. Kubrak T; Karakuła M; Czop M; Kawczyk-Krupka A; Aebisher D Molecules; 2022 Jan; 27(3):. PubMed ID: 35163996 [TBL] [Abstract][Full Text] [Related]
16. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Iinuma S; Schomacker KT; Wagnieres G; Rajadhyaksha M; Bamberg M; Momma T; Hasan T Cancer Res; 1999 Dec; 59(24):6164-70. PubMed ID: 10626808 [TBL] [Abstract][Full Text] [Related]
17. Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells. Szliszka E; Czuba ZP; Kawczyk-Krupka A; Sieron-Stoltny K; Sieron A; Krol W Med Sci Monit; 2012 Jan; 18(1):BR47-53. PubMed ID: 22207109 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with the novel photosensitizer chlorophyllin f induces apoptosis and autophagy in human bladder cancer cells. Lihuan D; Jingcun Z; Ning J; Guozeng W; Yiwei C; Wei L; Jing Q; Yuanfang Z; Gang C Lasers Surg Med; 2014 Apr; 46(4):319-34. PubMed ID: 24464873 [TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study. Berger AP; Steiner H; Stenzl A; Akkad T; Bartsch G; Holtl L Urology; 2003 Feb; 61(2):338-41. PubMed ID: 12597942 [TBL] [Abstract][Full Text] [Related]
20. An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer. Yavari N; Andersson-Engels S; Segersten U; Malmstrom PU Can J Urol; 2011 Aug; 18(4):5778-86. PubMed ID: 21854709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]